# Context Therapeutics (stock symbol: CNTX) Logo in transparent PNG and SVG formats

## Context Therapeutics Logo large

### Context Therapeutics Logo large Download PNG (45.32 KB)

![Context Therapeutics Logo large Download PNG (45.32 KB)](/img/orig/CNTX_BIG-6281fecf.png)

### Context Therapeutics Logo large Download SVG (26.16 KB)

![Context Therapeutics Logo large Download SVG (26.16 KB)](/img/orig/CNTX_BIG-1d76c5d5.svg)

## Context Therapeutics Logo icon format

### Context Therapeutics Logo icon format Download PNG (53.73 KB)

![Context Therapeutics Logo icon format Download PNG (53.73 KB)](/img/orig/CNTX-82206c13.png)

### Context Therapeutics Logo icon format Download SVG (16.16 KB)

![Context Therapeutics Logo icon format Download SVG (16.16 KB)](/img/orig/CNTX-8070879e.svg)

## Context Therapeutics Logo large for dark backgrounds

### Context Therapeutics Logo large for dark backgrounds Download PNG (28.38 KB)

![Context Therapeutics Logo large for dark backgrounds Download PNG (28.38 KB)](/img/orig/CNTX_BIG.D-1d9c2e4d.png)

### Context Therapeutics Logo large for dark backgrounds Download SVG (26.11 KB)

![Context Therapeutics Logo large for dark backgrounds Download SVG (26.11 KB)](/img/orig/CNTX_BIG.D-0e0dfe66.svg)

## Context Therapeutics Logo icon format for dark backgrounds

### Context Therapeutics Logo icon format for dark backgrounds Download PNG (32.51 KB)

![Context Therapeutics Logo icon format for dark backgrounds Download PNG (32.51 KB)](/img/orig/CNTX.D-dccb9f72.png)

### Context Therapeutics Logo icon format for dark backgrounds Download SVG (16.13 KB)

![Context Therapeutics Logo icon format for dark backgrounds Download SVG (16.13 KB)](/img/orig/CNTX.D-f29ba867.svg)

## About Context Therapeutics

Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therapeutics, such as anti-estrogen therapies across female hormone-dependent cancers. The company is also developing CLDN6xCD3 bsAb, an anti-CD3 x anti-Claudin 6 antigen bispecific monoclonal antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of an anti-claudin 6 bispecific monoclonal antibody for gynaecologic cancer therapy. Context Therapeutics Inc. was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.

1. Website domain: contexttherapeutics.com
2. Marketcap: $9.27 Million USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
